Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

Heart, Artery and Coronary Diseases
Do you want to read an article? Please log in or register.